Skip to main content
C

China Meheco Group Co., Ltd. — Investor Relations & Filings

Ticker · 600056 LEI · 300300PBRRWGVD4VNQ86 Shanghai Stock Exchange Wholesale and retail trade
Filings indexed 2,098 across all filing types
Latest filing 2026-04-24 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600056

About China Meheco Group Co., Ltd.

China Meheco Group Co., Ltd. is a comprehensive healthcare enterprise integrated into the global pharmaceutical supply chain. The company operates across the entire industrial spectrum, including research and development, cultivation of medicinal herbs, pharmaceutical manufacturing, international trade, and technical services. Its core business segments encompass the production and distribution of active pharmaceutical ingredients (APIs), finished medicines, medical devices, and traditional Chinese medicine. The organization leverages an extensive logistics network and retail pharmacy presence to facilitate healthcare delivery. By maintaining strategic partnerships and a robust international trade platform, the company provides integrated solutions for medical procurement and supply chain management. Its operations focus on ensuring the quality and accessibility of healthcare products through a vertically integrated business model that spans from raw material sourcing to end-user distribution.

Recent filings

Filing Released Lang Actions
董事会薪酬与考核委员会实施细则(2026年修订)
Regulatory Filings
2026-04-24 Chinese
关于2026年度为控股公司提供担保的公告
Regulatory Filings
2026-04-24 Chinese
2025年度非经营性资金占用及其他关联资金往来情况汇总表的专项审计报告
Regulatory Filings
2026-04-24 Chinese
关于召开2025年年度股东会的通知
Regulatory Filings
2026-04-24 Chinese
董事、高级管理人员离职管理制度
Regulatory Filings
2026-04-24 Chinese
2025年度环境、社会和公司治理(ESG)报告暨可持续发展报告摘要
Regulatory Filings
2026-04-24 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.